ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 709237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 709237; 2) Community: the network communities that were significantly associated with the response to NSC 709237; 3) Molecule: the relationships between components within communities and NSC 709237; 4) MDR: the compounds that were significantly associated with the NSC 709237.

NSC Compound Enrichment Correlation
NSC 621486 2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- 0.0252562667234373 0.21112354
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0252562667234373 0.007266535
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.0252562667234373 0.030031504
NSC 8120 Claviform 0.0252562667234373 0.05599386
NSC 128635 Null 0.0268790882218881 0.17377246
NSC 13484 Null 0.0268790882218881 -0.059958275
NSC 176323 Camptothecin Derivative 0.0268790882218881 0.82740975
NSC 295499 Camptothecin Derivative 0.0268790882218881 0.76261174
NSC 354051 LISCUNDITRIN 0.0268790882218881 0.020819917
NSC 374980 Acetamide, N-[2,3-bis(acetyloxy)-5,6,7,9-tetrahydro-1-methoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]-, (S)- 0.0268790882218881 0.062108609
Total:73  Current:43    [First] [Prev] [Next] [Last]